FOXO

FOXO Technologies Inc. Class A · AMEX

Sector Technology Services
Industry Packaged Software
Website foxotechnologies.com
Employees(FY) 4
ISIN US3514713052

Performance

-29.79%

+290.53%

+288.24%

+122.22%

+106.44%

YTD

+121.48%

Profile

FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.

Advanced Technical Analysis

Technical Analysis of FOXO 2024-11-20

The stock exhibits a strong bullish sentiment with a Moving Average Score of 90, indicating robust upward momentum, while the Oscillators Score of 46 suggests a neutral stance that may warrant caution. Overall, the Technical Score of 68 reinforces a generally positive outlook, though investors should remain aware of potential fluctuations indica...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of FOXO

Stock Rank

Recent News & Updates

2024-11-17 19:30
FOXO TECHNOLOGIES INC.'S BOARD OF DIRECTORS ANNOUNCES SPECIAL MEETING OF SHAREHOLDERS(Globenewswire)
2024-10-14 20:30
FOXO TECHNOLOGIES INC., PROVIDES UPDATE ON 2024 ACCOMPLISHMENTS AND PLANS FOR REMAINDER OF THE YEAR(Globenewswire)
2024-09-16 21:00
Foxo Technologies, Inc., Completes the Acquisition of Revenue Generating Operations From Rennova Health, Inc.(Globenewswire)
2024-08-07 20:30
FOXO Technologies Subsidiary, Myrtle Recovery Centers, Receives Two Full Licenses from the Tennessee Department of Mental Health and Substance Abuse Services(Globenewswire)
2024-07-16 04:30
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements(Globenewswire)
2024-06-30 20:30
Foxo Technologies, Inc., Regains Compliance with SEC Reporting Requirements(Globenewswire)
2024-06-17 20:30
FOXO Technologies Inc. Secures Up to $2.8 Million in Senior Notes to Fund Previously Announced Acquisition of Myrtle Recovery Centers, Inc. and Provide Additional Working Capital(Globenewswire)
2024-06-16 20:30
RENNOVA HEALTH, INC. ANNOUNCES STOCK EXCHANGE AGREEMENTS WITH FOXO TECHNOLOGIES, INC. FOR TWO OPERATING SUBSIDIARIES(Yahoo Finance)
2024-06-14 05:30
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements; Completes Steps it Believes are Required to Regain Compliance(Globenewswire)
2024-06-13 20:30
FOXO Technologies Enters into Share Exchange Agreements to Acquire Healthcare Operations from Rennova Health, Inc.(Globenewswire)
2024-04-23 05:00
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements(Globenewswire)
2024-02-13 20:32
FOXO Technologies Announces Non-Binding Agreement for Potentially Transformative Merger with M2i Global(Yahoo Finance)
2024-01-25 04:00
FOXO Technologies Announces Appointment of Capital Markets Veteran Francis Colt deWolf to the Board of Directors(Yahoo Finance)
2024-01-21 19:30
FOXO Technologies Formalizes License Agreement with KR8.ai to Power New Epigenetic Wellness Solutions(Yahoo Finance)
2023-12-18 19:30
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements(Yahoo Finance)
2023-11-30 20:01
FOXO Technologies On Track to Commence Commercial Rollout of VITHAR AI Health Coach in Early 2024(Yahoo Finance)
2023-11-29 03:30
FOXO Technologies Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q(Yahoo Finance)
2023-11-09 19:30
FOXO Technologies Provides Reminder for Webinar to be Held Today, November 10th at 10 AM Eastern Time, to Unveil VITHAR AI Health Coach(Yahoo Finance)
2023-11-07 20:00
FOXO Technologies to Unveil VITHAR AI Health Coach; Schedules Webinar for Friday, November 10th at 10 AM Eastern Time(Yahoo Finance)
2023-11-06 20:23
FOXO Technologies Expects Class A Common Stock to Resume Trading, Today, November 7, in Connection with 1-for-10 Reverse Stock Split(Yahoo Finance)
2023-10-29 20:30
FOXO Technologies Unveils Plans for New Direct-to Consumer Offering Combining the Companys Epigenetic Data with the Power of AI(Yahoo Finance)
2023-10-27 05:15
FOXO Technologies Inc. Announces Reverse Stock Split(Yahoo Finance)
2023-10-22 20:00
FOXO Technologies Completes Strategic Alternatives Review and Outlines Latest Progress Executing Corporate Strategy(Yahoo Finance)
2023-10-12 20:00
FOXO Technologies Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic Biomarkers(Yahoo Finance)
2023-10-05 20:30
FOXO Technologies Interim CEO Mark White Provides Letter to Shareholders Outlining New AI-Enabled Direct-to-Consumer Strategy and Immediate Expense Reductions(Yahoo Finance)
2023-09-05 20:30
FOXO Technologies Announces Agreement With Atrio Insurance(Yahoo Finance)
2023-08-30 20:30
FOXO Technologies Inc. Announces NYSE American Acceptance of Compliance Plan(Yahoo Finance)
2023-08-18 04:15
FOXO Technologies Inc. Announces Receipt of Second Notice of Non-Compliance from NYSE American(Yahoo Finance)
2023-08-16 20:30
FOXO Technologies Collaborates with DataRobot to Pave the Way for AI-Driven Epigenetic Biomarker Research in Human Longevity(Yahoo Finance)
2023-08-10 04:05
FOXO Technologies Announces Second Quarter 2023 Financial Results(Yahoo Finance)

Page 1 of 2

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.